The results are in. For the past four months, ACE has been receiving submissions and interviewing entrants to the inaugural Canada’s Best Workplaces for Employees Living with Arthritis. And the winners are: TELUS, Agricultural Financial Services Corporation and cfactor Works.
In this issue of JointHealth™ monthly, you will learn which three companies rose above the competition to win Canada’s Best Workplaces for Employees Living with Arthritis Award. As well, you will learn:
How the winners of the award were selected.
What you can do to communicate and engage with your employer about your arthritis.
How to participate in a research study entitled “Arthritis and Employment: Making it Work.”
TELUS, Agricultural Financial Services Corporation and cfactor Works recognized for best arthritis practices in the workplace
VANCOUVER, Sept. 25, 2014 /CNW/ – The results are in. Arthritis Consumer Experts (ACE) today announced the three companies awarded Canada’s Best Workplaces for Employees Living with Arthritis for their efforts to make the work environments great for everyone, including employees living with arthritis.
Based on workplace insights shared by employees and company managers, the following companies stand out for best practices that take into account the unique concerns of employees living with the most common chronic disease in the workplace – arthritis:
Commenting on the arthritis in the workplace award, ACE President, Cheryl Koehn said: “As we hoped, the application process delivered insights to further strengthen Canadian companies’ approaches to creating a more productive and arthritis sensitive workplace. During our exchanges with employees and employers, we also created opportunities for companies to assess their awareness of arthritis and support systems for employees living with the disease.”
Call for patient organization input on apremilast (Otezla®) for moderate to severe plaque psoriasis
Do you have moderate to severe plaque psoriasis or care for someone who does? If so, we need your valuable input.
The Common Drug Review (CDR) is currently welcoming patients and their caregivers to provide input to patient organizations on the manufacturer’s submission for apremilast (Otezla®) for the treatment of moderate to severe plaque psoriasis. Apremilast is an oral, small-molecule compound, taken as one tablet twice a day. In phase II and III clinical trials it has been shown to be effective and well tolerated for treating plaque psoriasis. The medication works by inhibiting the action of phosphodiesterase-4 (PDE4). PDE4 is an enzyme found in immune cells.
The Qualman-Davies Arthritis Consumer Community Leadership Award
Do you know a person with arthritis who has, or is, providing leadership in the community and deserves recognition for their valuable volunteer work? We encourage you to help us celebrate their contributions by nominating them for the Qualman-Davies Arthritis Consumer Community Leadership Award.
The Qualman-Davies Arthritis Consumer Community Leadership Award was created in 2014 to recognize one person’s contributions to helping all Canadians living with the disease to be heard in decision-making processes that affect millions. That’s what Ann Qualman and Jim Davies did as early pioneers in arthritis advocacy in Canada. Their tireless and selfless efforts helped millions of Canadians.
To submit a nomination, please follow the four steps listed below.
Obtain the prospective nominee’s consent to be nominated prior to submitting this form.
Click here to for the nomination form . If you create a separate nomination document, please use the headings provided on the Nomination Form PDF for ease of review by the award adjudication committee.
Provide the completed nomination form to the nominee for their review for accuracy and obtain their signature on the document.
The application deadline is October 10, 2014. Each submission will be reviewed by the award adjudication committee and scored on a points system. The successful nominee and their nominator will be provided notification of the award selection by the adjudication committee chair by October 17, 2014. The award will be bestowed in person at the Arthritis Alliance of Canada’s Annual Conference Gala, this year taking place on October 31, 2014 in Toronto, Ontario.
Government of BC awards ARC $3 million for arthritis research. Left to right: Ron McKerrow, ARC Board Chair; Minister Terry Lake, Minister of Health; Dr. John Esdaile, Scientific Director ARC; Minister Teresa Wat, MLA Richmond Centre; Linda Reid, Speaker of the House & MLA, Richmond East
The Government of BC donates $3 million for arthritis research.
The Government of British Columbia’s Health Minister, Terry Lake, made an incredible announcement during a press conference on Tuesday afternoon: $3 million dollars will go to the Arthritis Research Centre of Canada (ARC) to help further developments in arthritis prevention, diagnosis, and treatment.
As a disease that encompasses more than 100 forms, arthritis is the leading cause of disability. For this reason, its impact on the Canadian economy is estimated to be $33 billion each year in healthcare costs and lost productivity. During the announcement, Minister Lake said “With this investment, our government aims to help the Arthritis Research Centre continue to improve the lives of British Columbians living with arthritis, as well as reduce the burden arthritis puts on our healthcare system.” Continue reading →
Shortly following that, CTV News’ Eric Longley donned the “RA Experience Suit” and wandered around Ottawa’s Byward Market, getting a glimpse into what it’s like to live with rheumatoid arthritis. Click on “Suiting up for a Cause” to watch him attempt simple actions that most people not living with arthritis take for granted.
And just yesterday, the Richmond Review published an editorial article entitled, “Great work being done at arthritis research centre” about the Government of British Columbia’s donation of $3 million dollars to ARC to help further developments in arthritis prevention, diagnosis, and treatment. For more information on the government’s announcement, please click here.
Image courtesy of hywards at FreeDigitalPhotos.net